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A B S T R A C T
Objective: This observational study described the characterization of bacteria isolated 
from the lower respiratory tract of ventilated patients hospitalized in intensive care units. 
The demonstration of isolated microorganism resistance to antibiotics and a time-trend 
analysis of infection comparing a 48-month period were also other objectives. 
Method: Semi-quantitative assays of 1254 samples taken from 741 ventilated patients were 
performed, while pathogens were identified using the Enterotube II assay and VITEK 2 
Compact equipment. Bacterial resistance to antibiotics was assessed by the Kirby-Bauer disc 
diffusion method and time-trend analysis of infection was based on data recorded by hospital 
microbiology laboratories. 
Results: The most prevalent isolated bacteria from the patient’s lower respiratory tract were 
with Gram-negative bacteria (67.8%) mostly represented by: Acinetobacter spp. (25.2%), 
Pseudomonas spp. (18.3%) and Klebsiellas spp. (9.4%). Acinetobacter spp. showed moderate high 
to very high resistance to ceftriaxone (CRO), gentamicin (CN), amikacin (AK), meropenem 
(MRP), aztreonam (ATM) and piperacillin/tazobactam (TZP). Some isolates of Acinetobacter 
spp. resistant to colistin (CS) were identified in this patient population. Pseudomonas spp. and 
Klebsiella spp. were very highly resistant to ampicillin/sublactam (AMS) and with moderate or 
low resistance to CRO, ATM, MRP, AK, CN and TZP. A decrease in the Pseudomonas spp. prevalence 
rate was observed, whereas an increase in Acinetobacter spp. and Klebsiella spp. prevalence rates 
were observed in a 48-month period. 
Conclusion: This research corroborated that these nosocomial infections are a relevant medical 
problem in our context. The most prevalent bacterial infections in the lower respiratory tract of 
ventilated patients were by Acinetobacter spp., Pseudomonas spp. and Klebsiella spp. The panel 
of antibiotics used as preventive therapy was not the solution of infections and probably 
induced drug-resistance mechanisms in these isolated microorganisms.
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Introduction
The study of nosocomial infections has its origin in the 18th 
century thanks to the work of Sir John Pringle. As conclusion of 
this work, these infections were shown to be the most severe 
consequence of the massive use of hospitals.1 In connection 
with this conclusion, three major causes are involved in 
the generation of nosocomial infections: (1) the use of 
antimicrobial drugs; (2) some hospital personnel not following 
basic infection control procedures; and (3) patients in hospitals 
are increasingly immune-compromised. Nevertheless, organ 
transplantation, blood supply and hospital infrastructure 
renovations are also recognized as other causes of nosocomial 
infections.2 Among them and not surprisingly, nosocomial 
pneumonia is currently reported as the second higher cause 
of nosocomial infections, corresponding to about 18% of the 
total of nosocomial infections.
Since then (18th century), Staphylococcus aureus , 
Staphylococcus epidermidis, Gram-negative bacilli, Enterococcus 
spp., Candida spp., Klebsiella pneumoniae, Enterobacter spp. 
and Pseudomonas spp. have been the most frequently identified 
causative agents of nosocomial infections.3,4 On the other 
hand, in the 1990s, the three most common Gram-positive 
pathogens S. aureus, coagulase-negative Staphylococci, and 
Enterococci accounted for about 34% of nosocomial infections, 
while the four most common Gram-negative pathogens were 
Escherichia coli, Pseudomonas aeruginosa, Enterobacter spp., and 
K. pneumoniae accounting for about 32%.3,4
In parallel, bacterial antimicrobial resistance is another 
remarkable issue that challenges the efficacy of nosocomial 
infection treatment.5 In that sense, the development of the 
anti-microorganism drug families between 1950 and 1980 
stimulated the idea that the medical industry will always be 
one step forward of pathogenic microorganisms.6 However, it 
seems that the generation of new antibacterial drugs to fight 
bacterial pharmaco-resistance is stagnated.5 To exemplify 
this, the National Nosocomial Infection Surveillance System 
of the United States reported that methicillin resistant 
S. aureus (MRSA) was involved in 55% of nosocomial infections 
and about 26% of nosocomial infections were also associated 
with infections caused by Enterococcus resistant to vancomicin 
(VRE). Resistance to third generation cephalosporins was also 
reported for E. coli, K. pneumoniae and Enterobacter spp.6,7
All these data provide evidence on the importance of this 
relevant clinical problem. However, it is also noteworthy to 
emphasize that these nosocomial infections are not only 
the cause of a large number of deaths, but also their control 
is extraordinarily expensive. To illustrate this feature, it is 
estimated that the annual cost of nosocomial infections ranged 
from US$ 4 to 11 billion in the United States.8
Objectives
Considering this information, this observational study 
describes a characterization of bacterial infections in the 
lower respiratory tract of patients admitted in the ICUs at 
the Hermanos Ameijeiras Hospital with presumed nosocomial 
pneumonia. In addition to the resistance characterization of 
isolated microorganisms to antibiotics, a time-trend analysis 
of infection comparing a 48-month period was also conducted.
Materials and methods
General information of hospital 
The Hermanos Ameijeiras Hospital located in Cuba is a 625-
bed hospital with 15 medical wards, 12 surgical wards and 3 
intensive care units (ICUs). It provides assistance only for adults.
Patient sampling
A total of 1254 endotracheal secretion samples obtained 
from the lower respiratory tract of 741 ventilated patients 
were assessed. Samples of 2 mL were directly taken from 
patients by traqueal aspiration and subsequently inoculated 
in sterile tubes (13 mm x 100 mm) containing 5 mL of 0.9% 
saline solution. These samples were then immediately sent to 
the hospital’s microbiology laboratories.
Microbiological diagnosis
First, Gram staining was performed to detect polimorfonuclear 
leukocytes as prerequisite to then confirm the existence of 
bacterial infection. The culture of samples was performed 
using blood agar (BIOLIFE - Milano, Italy) supplemented with 
5% goat blood and MacConkey agar (BIOLIFE - Milano, Italy). 
All samples were processed according to methods described by 
the Institute of Clinical and Laboratory Standards of the United 
States. Next, plates were manually read after 24h and samples 
were considered positive when the concentration of bacteria 
was higher than 104 cfu/mL. Because of the obvious growth of 
multiple strains of bacteria, the majority of cultures required 
subsequent isolation on MacConkey agar (Gram-negative) and 
on blood agar (Gram-positive). Visualization was done using a 
stereo-microscope SZ71 (Olympus - Tokyo, Japan). 
After that, another Gram staining was performed to 
isolate cultures and to definitively corroborate the presence 
of Gram-negative bacilli and to assess purity of each culture. 
The isolated bacteria was then identified and tested for 
resistance to several antibiotics.
Assays for microorganism identification
A NN-dimethyl-p-phenylenediamine-oxalate assay was 
performed to separate Gram-negative microorganisms in 
two different groups. Then, the Enterotube II procedure 
[dexcarboxilase assay (Lysine and Ornitine)] was applied to 
Gram-negative and negative oxidase bacilli. Other Enterotube II 
assays such as carbohydrate fermentation (adonitol, arabinose, 
sorbitol, lactose, glucose, dulcitol), production of sulfidric acid, 
production of urease, citratase, and phenylalaline deaminase 
were performed. In addition, non-Enterotube II assays 
such as salted manitol, maltose, arginine, glucose oxidase 
were done. In some cases of non-fermenter bacilli, the use 
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of the Vitek 2 Compact equipment was absolutely necessary 
(bioMérieux Inc. – France). All positive oxidase bacilli were non-
fermenter bacilli and from this group, the group of Pseudomonas 
spp. was considered only as pathogen. Assays performed to 
classify microorganisms within the group of Pseudomonas spp. 
were glucose oxidation, pigment production, growing at 4°C 
and 42°C, respectively.
Assay for assessing microorganism resistance to antibiotics
All isolates were subjected to antimicrobial resistance 
testing against a panel of antibiotics using the Kirby-
Bauer disc diffusion method9 whereby the antibiotic will 
diffuse from a paper disc into the Müller-Hinton medium 
containing microorganisms and allowing the plate to dry up 
for 5 min. Growth inhibition was interpreted as a failure of 
microorganisms to grow in the antibiotic region. Paper discs 
containing known concentrations of antibiotics were applied to 
the surface and then incubated at 36 ± 1°C. The concentration 
of antibiotics used were as follows: 30 µg amikacin (AK), 
20 µg ampicillin/sublactam (AMS), 30 µg aztreonam (ATM), 
30 µg amoxicillin/clavulanate (AUG), 75 µg azlocillin (AZL), 
10 µg colistin (CS), 30 µg ceftriaxone (CRO), 30 µg cefoxitin 
(FOX), 30 µg chloranphenicol (C), 5 µg ciprofloxacin (CIP), 10 µg 
meropenem (MRP), 30 µg gentamicin (CN), 85 µg ticarcillin/
clavulanic acid (TIC), 50 µg sulfamethoxazole (SMX), 110 µg 
piperacillin/10 µg tazobactam (TZP). All microorganisms were 
diluted in 5 mL of Tryptic Soy Broth up to 0.5 McFarland. The 
appearance of the inhibition zone surrounding the discs indicated 
resistance of microorganisms, which was measured by comparing 
the diameter of the inhibition zones to a standard table. E. coli 
ATCC25922 and K. pneumoniae ATCC700603 served as reference 
samples (controls) in these assays.
Resistance of Acinetobacter spp. to CS was calculated by 
the use of the VITEK 2 Compact equipment estimating the 
minimum inhibitory concentration. 
Time-trend analysis of lower respiratory track nosocomial 
infection
In the period studied for the time-trend analysis of lower 
respiratory tract infections of patients, there were 6,087 cumulative 
samples of endotracheal secretion samples taken from patients 
admitted at the Hermanos Ameijeiras Hospital’s ICUs.
Statistical analysis
A single factor-ANOVA test was performed to compare 
the number of samples infected with Acinetobacter spp., 
Psedeudomonas spp. and Klebsiella spp. in the time-trend 
analysis of infections (from 2007 to 2010). The Tukey’s test 
was employed to discriminate statistical differences among 
the analyzed variables. The significance level applied was 
0.05 and the Statgraphics Plus version 5.0 (2000) from 
Statistical Graphics Corp. was used as tool for the statistical 
analysis.
Results 
As it was mentioned in the material and methods section 
and in Table 1, this study was carried out evaluating a total 
number of admitted patients and endotracheal secretion 
samples equal to 1060 and 1254, respectively. Evidently, 
the total number of patients admitted at the ICUs of the 
hospital and samples did not match because more than 
one sample was taken from some patients, at different 
moments, to confirm results. From this number of admitted 
patients, 741 (68.9%) received mechanical ventilation; and 
accounted to 125 deaths (11.8%) by sepsis and 58 deaths 
(5.5%) by causes not associated with infections. However, 
sepsis was also confirmed in these 58 cases by means of a 
rigorous anatomopathological examination.
Items Number of patients and samples Proportions (%)
Total number of patients admitted at the ICUs 1060 100.0
Total number of patients with mechanical ventilation 741 68.9
Total number of assessed samples from ventilated patients 1254 100.0
Patients with positive results to Gram-negative bacteria 503 67.8
Patients with positive results to Gram-positive bacteria 23 3.1
Patients with negative results 215 29.0
Assessed samples contaminated during the sampling 7 0.5
Assessed samples contaminated during the work in microbiology laboratories 7 0.5
Total of patients dead by generalized sepsis 125 11.8
Total of patients dead by unrelated causes but with generalized sepsis 58 5.5
Table 1 - Main data of the number of patients and infection rates in the lower respiratory tract of hospitalized 
patients in the ICUs
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As result of the microbiological assessments, 503 patients 
(67.8% of ventilated patients) were positive for Gram-negative 
bacteria whereas only 23 patients (3.1% of ventilated patients) 
were positive for Gram-positive bacteria. There was no lower 
respiratory track infection in the remaining 215 (29.0%) 
ventilated patients. In favor of the execution of this intensive 
microbiologic investigation, a very low level of contamination 
(1.1%) due to laboratory errors was observed (Table 1).
We also observed that 53.6% of infections were caused by 
bacteria of the Enterobacteriaceae family, where the most 
represented strains were Klebsiella spp. (35.7%). Likewise, 
we detected 43.5% of infections with non-fermenter bacilli, 
represented by Acinetobacter spp. (25.2%) and Pseudomonas spp. 
(18.3%) infections (Fig. 1).
Fig. 2 summarizes  resistance rates of Acinetobacter spp., 
Pseudomonas spp. and Klebsiella spp. to the panel of antibiotics 
mentioned above. This panel of antibiotics represents, perhaps, 
the most widely used antibiotics in the hospital during and/or 
before the studied period.
Data gathered in our study of bacterial resistance also 
corroborated the very high resistance of isolated Acinetobacter 
spp. to CRO (93%), CN (87%), AK (84%), MRP (81%), ATM (81%) 
and TZP (78%). However, the most remarkable findings of this 
study, something of greatest concern, was the isolation of 8 
(2%) samples of Acinetobacter baumannii resistant to CS and 
highly resistant to MPR (Fig. 2A).
Concerning the analysis of Pseudomonas spp. (Fig. 2B) 
and Klebsiella ssp. (Fig. 2C) resistance to antibiotics [there 
was moderate resistance (< 50%)] of Pseudomonas spp. to 
CN (45%), AK (40%), MRP (44%), ATM (51%). Furthermore, 
we also found a very high resistance of Pseudomonas spp. 
to AMS (92%), low to TZP (20%) and moderately high to 
CRO (68%). From this study, it can also be extrapolated that 
Klebsiella spp. were also moderately resistant to CN (45%), AK 
(38%), MRP (42%), ATM (34%). This group of bacteria showed 
low resistance to TZP (28%), high resistance to CRO (82%) 
and very high resistance to AMS (93%).
Fig. 1 - Collection of Gram-negative bacteria isolated from 
the lower respiratory tract of patients hospitalized in the 
ICUs. Gram-negative bacteria (darker) and Gram-positive 
bacteria (lighter).
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Fig. 2 - Antibiotic resistance patterns of (A) Acinetobacter 
spp., (B) Pseudomonas spp. and (C) Klebsiella spp. isolated 
from the lower respiratory tract of patients hospitalized in 
the ICUs.
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Finally, Fig. 3 illustrates a time-trend analysis of infections 
of the lower respiratory tract of patients admitted to the 
ICUs of the hospitals with Acinetobacter spp., Pseudomonas 
spp. and Klebsiella spp. infections. This comparison was done 
using recorded data of the last four consecutive years and 
the number of samples studied per year was as follows: 1626 
(2007), 1747 (2008), 1462 (2009), and 1254 (2010).
Our research revealed a decrease in the prevalence rate for 
Pseudomonas spp. (-1.19%) when 2007 and 2010 were compared. 
Nonetheless, an opposite time-trend in the prevalence rate was 
confirmed for Acinetobacter spp. and Klebsiella spp. An increase 
by approximately 4.5% was seen for Acinetobacter spp. from 
2009 to 2010. However, a linear increase for this nosocomial 
infection has been noticed since 2007 (y = 6.18x+1.55). 
The infection rate of Klebsiella spp. showed a dramatic increase 
in the last two years (11.3%).
The comparison of the respective infection rates 
demonstrated s igni f icant  d i f ferences  among the 
number of samples infected per year with Acinetobacter 
spp., Pseudomonas spp. and Klebsiella spp. (p = 0.027). 
The Tukey’s test confirmed ANOVA results, showing 
significant difference between the infection rates of 
Acinetobacter spp. and Klebsiella spp. Comparison between 
Pseudomonas spp. and Klebsiela spp. infection rates did not 
show significant difference (p = 0.053).
are those who receive assisted (mechanical) ventilation, 
which is directly associated with the increase in the length 
of hospital stay. As a general rule, patients that receive 
assisted ventilation develop pneumonia more frequently 
and are more likely to have a fatal outcome than those 
not requiring assisted respiration.11,12 In this respect, 
updated data from the U.S. National Healthcare Safety 
Network indicated that Gram-negative microorganisms 
(P. aeruginosa, and A. baumannii) predominate in the cases 
of nosocomial pneumonia.13
Taking into consideration this universal relevant clinical 
problem, we made a characterization of infection of the lower 
respiratory tract of 741 ventilated patients admitted to the 
ICUs with presumed nosocomial pneumonia. From these 
patients 1254 samples were collected and assessed by several 
microbiology tests. Some results were also corroborated by 
anatomopathological examination (Table 1).
The most general results evidenced that the majority 
of patients showed the presence of Gram-negative bacteria 
(67.8%) and 11.8% of patients died as consequence of 
generalized sepsis. Coincidentally, similar observations have 
been made by other investigators in the world. For instance, 
in the United States ICUs, infection with Gram-negative 
bacteria account for about 70% of nosocomial infections, 
but similar data have been reported from other parts of the 
world. In that sense, several Gram-negative microorganisms 
were responsible for those nosocomial infections, but among 
them, the Enterobacteriaceae family was the most commonly 
identified group overall.14 In 2006, it was estimated a death 
rate of 33% to 50% among patients who developed ventilator-
associated pneumonia. Furthermore, mortality was more 
likely when pneumonia was caused by Pseudomonas spp. or 
Acinetobacter spp.14
In addition to those findings, 53.6% of infections were 
caused by bacteria belonging to the Enterobacteriaceae 
family, but on the contrary the most commonly isolated 
bacteria within this family were Klebsiella spp. (35.7%). 
In addition, we also detected 43.5% of infections with non-
fermenter bacilli [Acinetobacter spp. (25.2%) and Pseudomonas 
spp. (18.3%)]. In regard to Acinetobacter spp., we would like to 
emphasize the fact that between 1986 and 2003, Acinetobacter 
species were the only Gram-negative microorganisms that 
increased markedly as cause of pneumonia in ICUs in the 
United States15 and unfortunately, the extraordinary 
resistance of these microorganisms to a wide spectrum of 
antibiotics has posed important therapeutic challenges.
Interestingly, our results were also consistent with 
those reported from the United States in 2010, where the 
most represented microorganisms found as cause of 
the nosocomial infections, were Klebsiella spp. accounted 
for about 20%.14,16,17 Equally, 72.9% of infections with non-
fermenter bacilli were reported in Kolar (India).
The high representativeness of these microorganisms in 
the nosocomial infections might be due to that most of them 
are found in the soil, water, intestinal tract and pharynx. 
They are also able to survive in wet places, soaps, mechanical 
respiration equipments (such as nebulizers, tracheal suction 
catheter, circuits of respirators) and pipes of difficult access to 
be washed and/or dried.
Fig. 3 - Time-trend analysis of infection of Acinetobacter 
spp., Pseudomonas spp. and Klebsiella spp. isolated from 
the lower respiratory tract of patients hospitalized in the 
ICUs.
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Discussion
Nosocomial infections are estimated to double mortality 
and morbidity risks of any hospital admitted patient. 
It has been estimated that about 1.7 million hospital-
acquired infections occurred and almost 99,000 deaths 
were associated with nosocomial infections, making it the 
sixth leading cause of death in the United States.3,4 Similar 
data have been reported from Europe.10 In this regard, 
the most susceptible patients to nosocomial pneumonia 
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The contamination of patients with Gram-negative bacteria 
represents a problem of a great clinical relevance, because the 
drug (antibiotic)-resistance mechanisms in these bacteria are 
increasingly being reported worldwide.13 Our investigation 
carried out to measure the resistance of the isolated bacteria 
to several antibiotics confirmed the high resistance of 
Acinetobacter spp. to CRO, CN, AK, MRP, ATM and TZP. Curiously, 
part of these results is controversial to those reported 
by Diomedi18 and Espinosa et al.19 Diomedi reported only 19% 
of Acinetobacter spp. resistance to MRP and Espinosa et al.,19 
only observed 60% of resistance of Acinetobacter spp. to MRP. 
Perhaps this difference could be explained by the development 
of drug resistance mechanisms in these strains. In this regard, 
it is important to realize that something similar might occur 
in future with the CS resistant variants of Acinetobacter spp. 
(A. baumannii) isolated in our conditions; if specials cares are 
not taken responsibly.
We also demonstrated a very low level of resistance 
of Acinetobacter spp. to CS, which is one of the last resort 
antibiotics for multidrug resistant A. baumannii and 
P. aeruginosa.20,21 Analogously, a previous study performed at 
the Hermanos Ameijeiras Hospital (2002-2006) by other group 
of researchers, also demonstrated the existence of Acinetobacter 
spp. in the ICUs.19 Although, the resistance of Acinetobacter spp. 
isolates to CS was not analyzed or reported in that study.
Our results were coincident with those described by 
Reis et al.22 This group reported up to 5% of resistance of 
Acinetobacter spp. to CS in a hospital in Brazil. However and 
surprisingly, none of these isolates were detected by the 
Kirby-Bauer disc diffusion assay. Nevertheless, something 
prominent of this work was that they elucidated the 
mechanism of resistance of these bacteria to CS, which was 
provoked by the membrane protein OprH-1, which interferes 
with the anionic linking site of polymyxins with the cell wall 
lipolysaccaride.
Other researchers have illustrated a similar phenomenon. 
For instance, Park et al.23 reported of the isolation of 63 isolates 
of Acinetobacter spp., from which 30.2% were resistant to CS and 
19 isolates corresponded to A. baumannii. Most of these isolates 
(84.2%) were collected from endotracheal aspirate, while others 
(15.8%) were from peritoneal fluid and sputum. Nevertheless, 
when all these isolates were characterized, all belonged to 
a single clone, ST22, and all contained the blaOXA-23 and 
blaOXA-66 genes. 
The mechanism of resistance to CS, Col(r),  in A. baumannii 
was analyzed by Adams et al.24 They selected in vitro Col(r) 
derivatives of the multidrug-resistant A. baumannii isolate 
(AB0057). The DNA sequencing identified mutations in genes 
encoding proteins PmrA and/or PmrB in each strain and also 
in a Col(r) clinical isolate. 
On the other hand, a low resistance to CN, AK, MRP, ATM 
and TZP was observed for Pseudomonas spp. and Klebsiella spp. 
The results observed with Pseudomonas spp., were expected 
and consistent with previous reports.25,26
In the United States, K. pneumoniae is important in 
nosocomial infections among adult and pediatric populations 
and accounted for approximately 8% of all nosocomial 
infections. Depending on the study reviewed, they comprise 
from 3% to 7% of all nosocomial bacterial infections, placing 
them among the top 8 pathogens in hospitals. K. pneumoniae 
cause as many as 14% of primary bacteremia cases and a 
significant increased mortality have resulted from infections 
with it.25 Thus, the extensive use of broad-spectrum antibiotics 
in hospitalized patients to treat this strain has probably led to 
the development of multidrug-resistant strains.27,28
According to our results, the most recommended antibiotics 
to be used as preventive therapy for either Pseudomonas spp. 
or Klebsiella spp. is TZP (< 28% of resistance).29 This antibiotic 
inhibits the action of bacterial betalactamases and its efficacy is 
amplified when is enriched by piperacillin, which is an extended 
spectrum betalactamic antibiotics of the ureidopenicillin class. 
As consequence, we hypothesize, that the use of these 
antibiotics to treat preventively patients infected with 
this kind of bacteria (Acinetobacter spp., Pseudomonas spp. 
and Klebsiella spp.) was the non-solution of infections and 
perhaps the stimulation of drug-resistance mechanisms by 
these microorganisms. Therefore, the application of most 
of the antibiotics (the ones mentioned above and others) as 
preventive therapy is considered unsuitable; mostly when 
a microbiologic assay employed to identify microorganisms 
and select the proper antibiotic can be performed in a relative 
short period of time. In such sense, the administration of an 
empirical antibiotic therapy should not only be delayed in 
severely ill patients, on account of the diagnostic procedure; 
because in any other medical situation the inappropriate use 
of antibiotics could only increase the morbidity and mortality, 
contribute to the development of bacteria-drug resistance 
mechanisms and in conclusion increase health care costs.
Finally, this study team also considered prudent presenting 
to the specialized readers a trend-time analysis of these 
three bacterium associated-nosocomial infections. As 
complementary information we must share that a previous 
resembling trend-time study was performed in this hospital, 
2002-2006. This study also demonstrated the predominance 
of Gram-negative bacteria in the ICUs, particularly, non-
fermentative bacilli such as Acinetobacter spp. and Psedudomas 
spp., with almost a generalized growth of the microorganism 
resistance patterns; but not Klebsiella ssp. This study also 
demonstrated the very high resistance of Acinetobacter spp. 
to CRO (88-96%) and a moderate resistance to MRP (55-62%). 
In that revision, the group of Gram-positive bacteria was 
represented by S. aureus with an evident resistance to oxacillin, 
but all were very low resistance (0%) to vancomicyn.19
However, the time-trend analysis performed in our research 
verified a decrease in the infection rate for Pseudomonas spp., 
but a marked increase in the infection rates for Acinetobacter 
spp. and Klebsiella spp. Perhaps, these results might be 
attributable to the fact that Pseudomonas spp. were the most 
susceptible bacteria to the panel of antibiotics employed 
preventively. As it can be observed, in the last two years, the 
highest shift in the infection of the patient’s lower respiratory 
tracks was produced by Klebsiella spp. reaching a value of 11.6%. 
We hardly recommend that such time-trend of infections 
with Klebsiella  spp. and Acinetobacter  spp. has to be 
decreased by the no treatment of patients in the community 
with antibiotics, deliberate prescription, before receiving 
attention in the hospital, modifications in the surveillance 
strategies, development and/or use of non-invasive 
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infection-resistant devices and the most importantly health-
care workers should urgently improve their work in order 
to get a better consolidation of prevention practices for 
nosocomial infections.
In summary, this research corroborated that these 
nosocomial infections are a relevant medical problem in our 
context as it is in all over the world. It also shown that the most 
prevalent infections with bacteria in the lower respiratory track 
of ventilated patients admitted at the ICUs of the hospital were 
caused by Acinetobacter spp., Pseudomonas spp. and Klebsiella 
spp. The use of the panel of antibiotics employed to treat this 
type of infections, as preventive therapy, was the non-solution 
of infections and probably the induction of drug-resistance 
mechanisms in these isolated microorganisms. Some isolates 
of Acinetobacter spp. resistant to CS were identified in our 
conditions and finally, a decrease in the prevalence rate for 
Pseudomonas spp. was observed, although an opposite time-
trend of infections with Acinetobacter spp. and Klebsiella spp. 
was corroborated in a 48-month period.
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